119 related articles for article (PubMed ID: 1339876)
21. Colorectal cancer metastases: surgical indications and multimodal approach.
Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
[TBL] [Abstract][Full Text] [Related]
22. Reappraisal of preoperative carcinoembryonic antigen levels as a prognostic factor in resectable colorectal cancer.
Tsuchiya A; Ando Y; Kikuchi Y; Kanno M; Sato H; Yoshida T; Abe R
Fukushima J Med Sci; 1994 Jun; 40(1):9-17. PubMed ID: 7988985
[TBL] [Abstract][Full Text] [Related]
23. [Surgical treatment of pulmonary metastases of colorectal cancers. 8-year survival and main prognostic factors].
Baron O; Hamy A; Roussel JC; Galetta D; al Habash O; Duveau D; Despins P; de Lajartre AY; Michaud JL
Rev Mal Respir; 1999 Nov; 16(5):809-15. PubMed ID: 10612150
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer.
Maxwell-Armstrong C; Scholefield J
Clin Evid; 2002 Jun; (7):406-13. PubMed ID: 12230666
[No Abstract] [Full Text] [Related]
25. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
Grotowski M
Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
[TBL] [Abstract][Full Text] [Related]
26. [Follow-up of patients after curative surgery for colorectal cancer].
Wille-Jørgensen PA; Madsen MR
Ugeskr Laeger; 2005 Oct; 167(44):4189-91. PubMed ID: 16266577
[TBL] [Abstract][Full Text] [Related]
27. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases.
Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Togo S
Ann Surg Oncol; 2007 Apr; 14(4):1336-46. PubMed ID: 17235718
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic importance of preoperative CEA in patients with colorectal cancer].
Turoldo A; Balani A; Scaramucci M; Babic F; Guidolin D; Liguori G
Chir Ital; 2002; 54(4):469-76. PubMed ID: 12239755
[TBL] [Abstract][Full Text] [Related]
29. [After care in colorectal cancer].
Brunner H
Wien Med Wochenschr; 1988 Jun; 138(11-12):261-3. PubMed ID: 3176505
[TBL] [Abstract][Full Text] [Related]
30. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
Park JY; Lee KH
Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of serum CEA determination in the diagnosis of colo-rectal cancer].
Jiang R
Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):348-51. PubMed ID: 2620629
[TBL] [Abstract][Full Text] [Related]
32. Re-operation for recurrent colorectal cancer: the importance of early diagnosis for resectability and survival.
Quentmeier A; Schlag P; Smok M; Herfarth C
Eur J Surg Oncol; 1990 Aug; 16(4):319-25. PubMed ID: 2379591
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of preoperative chemoradiation in rectal cancer patients aged 70 and older.
Mantello G; Berardi R; Cardinali M; Fabbietti L; Fenu F; Montisci M; Iovini G; Delprete S; Mattioli R; Cascinu S; Grillo-Ruggieri F
J Exp Clin Cancer Res; 2005 Dec; 24(4):541-6. PubMed ID: 16471316
[TBL] [Abstract][Full Text] [Related]
34. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
35. [Patient compliance and efficacy of diagnostic procedures in the surveillance of colorectal cancer: experience from a cancer center].
Riedl S; Lux T; Abel U; Theuer D
Z Gastroenterol; 2005 Apr; 43(4):357-65. PubMed ID: 15830301
[TBL] [Abstract][Full Text] [Related]
36. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].
Scheithauer W
Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy for colorectal cancer.
Kerr DJ; Gray R
Br J Hosp Med; 1996 Mar 6-19; 55(5):259-62. PubMed ID: 8777517
[No Abstract] [Full Text] [Related]
38. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
[TBL] [Abstract][Full Text] [Related]
39. Progress in the treatment of colorectal cancer.
Kanellos I
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s1-2. PubMed ID: 15655586
[No Abstract] [Full Text] [Related]
40. Value of follow-up in the management of recurrent colorectal cancer.
Camuñas J; Enriquez JM; Devesa JM; Morales V; Millan I
Eur J Surg Oncol; 1991 Oct; 17(5):530-5. PubMed ID: 1936302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
